METHOD OF MAGNETIC RESONANCE IMAGING
    53.
    发明公开
    METHOD OF MAGNETIC RESONANCE IMAGING 有权
    FOR成像方法磁共振

    公开(公告)号:EP1181571A1

    公开(公告)日:2002-02-27

    申请号:EP00935304.6

    申请日:2000-05-22

    IPC分类号: G01R33/563

    CPC分类号: G01R33/563 G01R33/281

    摘要: A method of magnetic resonance imaging of the kidney in a vascularised human or non human body wherein a blood pool MR contrast agent, preferably a paramagnetic contrast agent, is administered as a bolus into the vasculature of said body and images of said kidney are generated using imaging sequences and timing to permit both visualisation and gradation of renal artery stenosis and quantification of renal perfusion, and, optionally, values indicative of renal artery stenosis grade and renal perfusion are generated from said images. Preferably, T2*-weighted images are generated during the first pass T1- weighted images are generated. after the concentration of contrast agent throughout the blood has become substantially uniform.

    PROCESS FOR THE PREPARATION OF CONTRAST AGENTS
    56.
    发明授权
    PROCESS FOR THE PREPARATION OF CONTRAST AGENTS 失效
    用于生产造影剂

    公开(公告)号:EP0923537B1

    公开(公告)日:2001-10-31

    申请号:EP97937743.9

    申请日:1997-08-29

    IPC分类号: C07C231/08

    CPC分类号: C07C231/08

    摘要: The invention provides a process for the preparation of an N-alkyl-acylamino-phenyl-carboxylic acid or carboxylic acid derivative by liquid phase acylation and subsequent N-alkylation of a corresponding amino-phenyl-carboxylic acid (or carboxylic acid derivative), the improvement comprising the addition of an alkylating agent to a solution containing the reaction products of said acylation, to effect said N-alkylation.

    CONTRAST AGENTS WITH VARIABLE OXIDATION STATES
    57.
    发明公开
    CONTRAST AGENTS WITH VARIABLE OXIDATION STATES 审中-公开
    CONTRAST氧化水平的变NUMBER

    公开(公告)号:EP1123116A2

    公开(公告)日:2001-08-16

    申请号:EP99950946.6

    申请日:1999-10-22

    发明人: KELLAR, Kenneth

    IPC分类号: A61K49/00

    CPC分类号: A61K49/06

    摘要: The invention relates to the use as a contrast agent in MR imaging of a physiologically tolerable lanthanide compound or salt thereof having first and second oxidation states which differ in relaxivity by a factor of at least 5, and which is convertible in vivo from said first to said second oxidation state whereby contrast is enhanced in a body region in which conversion to said second state does or does not occur.

    Cap for container
    58.
    发明公开
    Cap for container 有权
    VerschlusskappefürBehälter

    公开(公告)号:EP1122185A2

    公开(公告)日:2001-08-08

    申请号:EP01101704.3

    申请日:2001-01-25

    IPC分类号: B65D51/00

    CPC分类号: B65D51/002 B65D55/024

    摘要: A package (10) comprises a container (20), a closure member (40) removably inserted into the mouth of the container, and a cap (50). The cap has a cover member (52) which overlies the closure and has a region (66) which is removable to expose the upper surface of the closure to allow piercing thereof by a needle or the like. The removable region is provided with a pull-ring (68) protected from accidental operation by a protective portion (60) projecting upwardly from the edge of the cover member (52). The protective portion is formed separately from the rest of the cap and is attached thereto.

    摘要翻译: 包装(10)包括容器(20),可拆卸地插入容器的口中的封闭构件(40)和盖(50)。 帽具有盖构件(52),该盖构件覆盖在封闭件上并且具有可移除以暴露封闭件的上表面的区域(66),以允许通过针或类似物刺穿它。 可移除区域设置有通过从盖构件(52)的边缘向上突出的保护部分(60)而防止意外操作的拉环(68)。 保护部分与盖的其余部分分开形成并附接到其上。

    METHOD OF MAGNETIC RESONANCE IMAGING
    59.
    发明公开
    METHOD OF MAGNETIC RESONANCE IMAGING 审中-公开
    方法磁成像的

    公开(公告)号:EP1118009A1

    公开(公告)日:2001-07-25

    申请号:EP99947646.8

    申请日:1999-09-21

    IPC分类号: G01R33/28

    CPC分类号: G01R33/5601

    摘要: The invention provides a method of magnetic resonance imaging of regional blood oxygenation which comprises administering into the vasculature of a vascularised human or non-human animal subject a T2 blood pool contrast agent, detecting a magnetic resonance signal from at least part of the vasculature of said subject into which said contrast agent distributes, and manipulating said signal to generate an indication of the partial pressure of oxygen (pO2) in at least part of said vasculature.